Targtex
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2023-07-01attributed |
| Founded | unknown |
| Headquarters | Torres Vedras, Portugal |
| Industry | biotech |
| Stage | unknown |
| Website | targtex.com |
TargTex develops localized therapies for glioblastoma, with a lead surgical-adjunct drug targeting an unexplored protein in the tumor. It is built for glioblastoma patients with few treatment options. Its targeted local delivery aims to act as a surgical adjunct rather than a systemic therapy.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-07-01 | grant | $2.7M | undisclosed |
Detected tech stack
LiteSpeed, PHP 7.4.33, WordPress 5.2.4, Amazon Web Services, Modernizr, Google Maps, Slider Revolution, Stellar.js, jQuery Migrate, parallax.js, Contact Form 7, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | targtex.com, read 2026-05-08 |
| Description | self-reported | targtex.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.